4SC AG INH. O.N./ DE000A3E5C40 /
19/06/2024 21:55:02 | Chg. -0.300 | Volume | Bid22:00:00 | Ask22:00:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
6.900EUR | -4.17% | 401 Turnover: 2,886.640 |
-Bid Size: - | -Ask Size: - | 68.78 mill.EUR | 0.00% | - |
GlobeNewswire
05/12/2023
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
01/04/2019
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
11/06/2018
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018